Unicycive Historical Cash Flow
| UNCY Stock | USD 0.69 0.01 1.47% |
Analysis of Unicycive Therapeutics cash flow over time is an excellent tool to project Unicycive Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 9.7 M or Other Cashflows From Financing Activities of 28.9 M as it is a great indicator of Unicycive Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Unicycive Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Unicycive Therapeutics is a good buy for the upcoming year.
Unicycive |
About Unicycive Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Unicycive balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Unicycive's non-liquid assets can be easily converted into cash.
Unicycive Therapeutics Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Unicycive Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Unicycive Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Unicycive Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Unicycive Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Unicycive Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Unicycive Stock please use our How to Invest in Unicycive Therapeutics guide.At this time, Unicycive Therapeutics' Change In Cash is fairly stable compared to the past year. Other Cashflows From Financing Activities is likely to rise to about 28.9 M in 2024, despite the fact that Net Borrowings is likely to grow to (12.8 K).
| 2010 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 29K | 2K | 12K | 17.3K | Depreciation | 13K | 161K | 284K | 298.2K |
Unicycive Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Unicycive Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Unicycive Therapeutics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (10K) | (15K) | 16.6M | (16.1M) | 9.2M | 9.7M | |
| Total Cash From Operating Activities | (1.2M) | (1.5M) | (5.8M) | (15.7M) | (18.3M) | (17.4M) | |
| Net Income | (2.2M) | (2.3M) | (10.0M) | (18.1M) | (30.5M) | (29.0M) | |
| Total Cash From Financing Activities | 1.2M | 1.4M | 22.4M | (471K) | 27.5M | 28.9M | |
| End Period Cash Flow | 15K | 147K | 16.6M | 455K | 9.7M | 4.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Unicycive Stock Analysis
When running Unicycive Therapeutics' price analysis, check to measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.